University of Ulm
4 clinical trials · 4 recruiting · OTHER
Trials by University of Ulm
RECRUITINGNCT06877143
Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis
Weight loss is a known negative prognostic factor in amyotrophic lateral sclerosis (ALS). Over the last years, various interventional studies targeting the energy deficit in ALS...
Sponsor: University of UlmEnrolling: 761 location
Amyotrophic Lateral Sclerosis (ALS)
RECRUITINGNCT06280079
Ultra-high-caloric, Fatty Diet in ALS
This study aims at evaluating efficacy and tolerability of an ultra-high-caloric, fatty diet (UFD) compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
Sponsor: University of UlmEnrolling: 39220 locations
Amyotrophic Lateral Sclerosis
RECRUITINGNCT04820478
Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS)
Weight loss is a known negative prognostic factor in amyotrophic lateral sclerosis (ALS). One potential mechanism of weight loss in ALS is a disturbance of the mitochondrial...
Sponsor: University of UlmEnrolling: 761 location
Amyotrophic Lateral Sclerosis
RECRUITINGNCT03044223
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
The present study focuses on patients with Pseudomonas aeruginosa (PSA) sepsis. The aim of the present study is to find out whether the M1 (pro-inflammatory) or M2...
Sponsor: University of UlmEnrolling: 1001 location
Pseudomonas InfectionsPseudomonas SepticemiaPseudomonas; Pneumonia+6